Our results showing that CD109 is not a direct target of TGF-β in SSc and normal skin fibroblasts suggests that CD109 upregulation in SSc fibroblasts may involve TGF-β-independent mechanisms. This evidence concerns the gene TGFB1 and systemic sclerosis.